Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

101 - 110of 392 News
101 - 110of 392 News
June 08, 2022
Bayer’s BlueRock Therapeutics establishes European site for cell therapy innovation
READ MORE
May 23, 2022
Not intended for U.S. and UK Media - Late-breaking data from exploratory post hoc analysis of prespecified pooled analysis FIDELITY presented at Heart Failure 2022 of the Heart Failure Association of the European Society of Cardiology (ESC)
New data support renal and cardiovascular benefits of Kerendia™ (finerenone) in patients with and without history of left ventricular hypertrophy and chronic kidney disease and type 2 diabetes
READ MORE
May 19, 2022
Not intended for U.S. and UK Media
Verquvo™ (vericiguat) approved in China to treat patients with chronic heart failure and reduced ejection fraction
READ MORE
May 10, 2022
First quarter at Bayer:
Very good start to the year - strong sales and earnings growth
READ MORE
May 03, 2022
Not intended for U.S. and UK Media
U.S. FDA accepts supplemental new drug application (sNDA) and grants priority review for darolutamide in combination with docetaxel for metastatic hormone-sensitive prostate cancer (mHSPC)
READ MORE
April 29, 2022
CEO Werner Baumann at the Annual Stockholders’ Meeting:
"Bayer is on the right track"
READ MORE
April 22, 2022
Not intended for U.S. and UK Media
Bayer submits application in China for additional indication of darolutamide
READ MORE
April 13, 2022
Not intended for U.S. and UK Media
Bayer receives approval for precision oncology treatment Vitrakvi™ in China
READ MORE
April 03, 2022
Not intended for U.S. and UK Media - American College of Cardiology’s 71st Annual Scientific Session (ACC.22):
Bayer presents positive results from first Phase 2b trial on safety of asundexian in patients with atrial fibrillation
READ MORE
April 01, 2022
Breakthrough Innovation Forum
Bayer set to drive breakthrough innovations in the Life Sciences
READ MORE
101 - 110of 392 News
101 - 110of 392 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more